3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 3
3
Phase 1
2
Phase 1/2
1
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Tumor-Agnostic
1
Conditions
Breast Neoplasms
2
Neoplasms
1
Interventions
pembrolizumab
81
Carboplatin
76
Magnetic Resonance Spectroscopy
73
Specimen Handling
69
Cisplatin
62
Paclitaxel
55
Gemcitabine
46
Fluorouracil
37
Dexamethasone
37
Radiation
36
Docetaxel
36
Cyclophosphamide
36
Radiotherapy
35
Pemetrexed
35
Doxorubicin
35
Oxaliplatin
33
Leucovorin
33
Bevacizumab
31
Capecitabine
28
Vincristine
27
durvalumab
26
Etoposide
24
Rituximab
23
Taxes
22
Irinotecan
22
Nivolumab
21
Letrozole
21
Prednisone
20
Biopsy
20
Platinum
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
inavolisib
×
30 days
×
Clear all
NCT05862285
2026-05-12
UmbrellaMAX
Hoffmann-La Roche
Phase 3
Recruiting
100 enrolled
NCT05646862
2026-05-06
INAVO121
Hoffmann-La Roche
Phase 3
Active not recruiting
420 enrolled
NCT06790693
2026-05-04
INAVO123
Hoffmann-La Roche
Phase 3
Recruiting
450 enrolled